Free semaglutide unit calculator. Convert a compounded semaglutide dose in mg to units on a U-100 insulin syringe, with the concentration math shown.

30-Second Clinical Verdict: On a standard U-100 insulin syringe (where 100 units = 1.0 mL), syringe markings depend entirely on your vial's concentration. For the most common concentration of 2.5 mg/mL (5 mg in 2 mL), a starting dose of 0.25 mg is 10 units , 0.50 mg is 20 units , 1.0 mg is 40 units , and 1.7 mg is 68 units . For a 5.0 mg/mL vial (5 mg in 1 mL), cut those markings in half: 0.25 mg is 5 units , and 0.50 mg is 10 units . Always verify the mg/mL printed on your vial before injecting.

Frequently Answered Clinical Questions:

• How many units is a 0.25 mg dose of semaglutide?
  It depends entirely on your vial's concentration. Divide total mg by total mL to get mg per mL, divide your dose by that number to get millilitres, then multiply by 100 for units on a U-100 syringe.
• How many units is 0.5 mg, 1 mg, or 1.7 mg of semaglutide?
  At a standard concentration of 2.5 mg/mL (5 mg in 2 mL), 0.25 mg is 10 units, 0.5 mg is 20 units, 1.0 mg is 40 units, and 1.7 mg is 68 units on a U-100 syringe. Always verify the concentration printed on your vial.
• How do I convert mL to insulin units?
  On a standard U-100 insulin syringe, 1.0 mL equals 100 units. To convert mL to units, multiply the volume in mL by 100 (for example, 0.1 mL = 10 units, and 0.125 mL = 12.5 units).
• Does this work for Ozempic and Wegovy pens?
  No. Brand-name pens are dialled or preset in milligrams and are never drawn into a syringe. This tool is for compounded vials.

Use the free interactive calculator on GLPme →

GLPme is 100% free and on-device private on iPhone. No accounts, no paywalls.

Free tirzepatide unit calculator. Convert a compounded tirzepatide dose in mg to units on a U-100 insulin syringe, with the concentration math shown.

30-Second Clinical Verdict: On a standard U-100 insulin syringe (where 100 units = 1.0 mL), tirzepatide syringe marks depend strictly on your vial's concentration. At a standard 10 mg/mL strength, the starting dose of 2.5 mg is 25 units , 5.0 mg is 50 units , and 7.5 mg is 75 units . At a concentrated 20 mg/mL strength (common for higher doses), 2.5 mg is 12.5 units , 5.0 mg is 25 units , 7.5 mg is 37.5 units , 10 mg is 50 units , and 15 mg is 75 units . Always confirm total mg and total mL on your pharmacy label.

Frequently Answered Clinical Questions:

• How many units is a 2.5 mg dose of tirzepatide?
  It depends entirely on your vial's concentration. Divide total mg by total mL to get mg per mL, divide your dose by that number to get millilitres, then multiply by 100 for units on a U-100 syringe.
• How many units is 5 mg, 7.5 mg, or 10 mg of tirzepatide?
  At a standard concentration of 10 mg/mL, 2.5 mg is 25 units, 5 mg is 50 units, and 7.5 mg is 75 units (or half those units at 20 mg/mL) on a U-100 syringe. Always verify the concentration printed on your vial.
• How do I convert mL to insulin units?
  On a standard U-100 insulin syringe, 1.0 mL equals 100 units. To convert mL to units, multiply the volume in mL by 100 (for example, 0.1 mL = 10 units, and 0.125 mL = 12.5 units).
• Does this work for Mounjaro and Zepbound pens?
  No. Brand-name pens are dialled or preset in milligrams and are never drawn into a syringe. This tool is for compounded vials.

Use the free interactive calculator on GLPme →

GLPme is 100% free and on-device private on iPhone. No accounts, no paywalls.

Free peptide reconstitution calculator: calculate bacteriostatic water volume, vial concentration (mg/mL), and exact syringe units for semaglutide, tirzepatide, and peptides. Zero signup.

Frequently Answered Clinical Questions:

• How much bacteriostatic water should I add to a 5 mg peptide vial?
  Adding 2.0 mL of bacteriostatic water to a 5 mg vial creates a concentration of 2.5 mg/mL (25 mcg per syringe unit). At this concentration, a 0.25 mg starting dose is exactly 10 units on a standard U-100 syringe. If you add 1.0 mL instead, your concentration is 5.0 mg/mL and a 0.25 mg dose is 5 units.
• What is the formula to calculate syringe units for reconstituted peptides?
  The universal formula is: Syringe Units = (Prescribed Dose in mg / Vial Concentration in mg/mL) * 100. To find your vial concentration, divide the total peptide mg in the vial by the mL of bacteriostatic water added.
• Can you shake a peptide vial after adding bacteriostatic water?
  No. Never shake peptide vials. Shaking causes foaming, shearing, and denaturation of the fragile peptide amino acid chains. Instead, inject the liquid slowly down the inside glass wall and gently roll or swirl the vial between your fingers until fully dissolved.
• How long is reconstituted peptide good for in the refrigerator?
  Once reconstituted with bacteriostatic water containing 0.9% benzyl alcohol, vials should be stored between 36°F and 46°F (2°C–8°C) and used within 28 to 30 days. Protect from direct heat and light.
• What syringe should I use for reconstituted peptides?
  Standard U-100 insulin syringes with attached 31-gauge, 5/16-inch (8mm) needles are the industry standard for subcutaneous peptide injections. 100 units on a U-100 syringe equals exactly 1.0 mL.

Use the free interactive calculator on GLPme →

GLPme is 100% free and on-device private on iPhone. No accounts, no paywalls.

Free GLP-1 titration schedule calculator. Standard dose escalation steps and dates for Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda and Rybelsus.

Frequently Answered Clinical Questions:

• How long do you stay on each GLP-1 dose?
  The standard label schedule holds each step for four weeks before escalating, with Saxenda stepping weekly and Rybelsus monthly. Prescribers commonly hold a dose longer when side effects have not settled.
• What is the maximum dose of Zepbound?
  15 mg weekly is the top of the standard escalation, reached through 2.5, 5, 7.5, 10 and 12.5 mg steps.

Use the free interactive calculator on GLPme →

GLPme is 100% free and on-device private on iPhone. No accounts, no paywalls.

Calculate a safe transition calendar when changing your GLP-1 injection day. Complies with FDA 48h (Ozempic/Wegovy) and 72h (Mounjaro/Zepbound) minimum spacing rules to prevent dose stacking nausea.

30-Second Clinical Verdict: Yes, you can safely change your weekly GLP-1 injection day, provided you never violate the FDA minimum spacing rule between consecutive doses. For semaglutide (Ozempic/Wegovy) , consecutive doses must be spaced at least 48 hours (2 days) apart. For tirzepatide (Mounjaro/Zepbound) , doses must be spaced at least 72 hours (3 days) apart. Taking a dose closer than this window causes acute peak-dose stacking, triggering severe nausea, intractable vomiting, and dehydration. If your desired new day requires shortening the gap too much, a 1-day step shift or an extended interval bridge is the clinically recommended protocol.

Frequently Answered Clinical Questions:

• Can I change my Ozempic or Wegovy injection day?
  Yes. Section 2.2 of the FDA prescribing label states you may change your weekly injection day as long as the time between two doses is at least 48 hours (2 days). You can shorten the interval down to 2 days or extend it up to 5 days late.
• Can I take Mounjaro or Zepbound 2 days early?
  No. The FDA label for tirzepatide specifies a minimum spacing of 72 hours (3 full days) between doses. Taking Mounjaro after only 48 hours violates this safety window and causes severe dose-stacking nausea. You may take it up to 3 days early, but never closer than 72 hours.
• What is the best day of the week to take my GLP-1 injection?
  Many patients choose Thursday evening or Friday morning. Because GLP-1 medications peak 24 to 48 hours post-shot, peak appetite suppression covers Friday night, Saturday, and Sunday — the days when social dining, alcohol, and cravings are highest.
• What happens if I take two doses too close together?
  Injecting doses closer than the FDA minimum spacing stacks the new dose on top of circulating drug from the previous week, spiking peak blood concentrations by up to 180% and triggering severe projectile vomiting, nausea, and dehydration.

Use the free interactive calculator on GLPme →

GLPme is 100% free and on-device private on iPhone. No accounts, no paywalls.

GLP-1 dose calculator for switching medications: Ozempic to Mounjaro, Wegovy to Zepbound. See FDA starting doses, full titration paths, and why no direct equipotency conversion table exists.

30-Second Clinical Verdict: There is no direct milligram-to-milligram conversion when switching between semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound). Because semaglutide is a selective GLP-1 receptor agonist and tirzepatide is a dual GIP/GLP-1 receptor agonist, gastrointestinal tolerance built on one medication does not transfer to the other. Official FDA prescribing guidance requires starting at the lowest label starting dose ( 2.5 mg weekly for tirzepatide ; 0.25 mg weekly for semaglutide ) with a 7-day washout from your last injection to avoid severe nausea, vomiting, or pancreatitis.

Frequently Answered Clinical Questions:

• What Zepbound dose is equivalent to 2.4 mg Wegovy?
  None. There is no published equipotency between semaglutide and tirzepatide, because the trials that would establish one have not been run. The Zepbound label starts everyone at 2.5 mg weekly.
• What dose of Mounjaro corresponds to 1 mg of Ozempic?
  There is no direct equivalent. Under FDA guidance, patients switching from 1 mg Ozempic to Mounjaro restart at 2.5 mg weekly for 4 weeks before evaluating step-up to 5.0 mg.
• Do I have to start over when switching GLP-1 medications?
  Usually yes. Prescribers typically restart at the new drug's label starting dose and titrate up, because tolerance is largely specific to the molecule you built it on.
• Can I switch from Wegovy to Zepbound at the same dose?
  No. They are different molecules with different receptor targets, so the milligram numbers are not comparable. Some prescribers start a step above the lowest for someone who tolerated a high dose well.
• How long should I wait between my last dose and starting the new medication?
  For two weekly medications, prescribers commonly start the new one when the next old dose would have been due. Confirm the timing with your prescriber, since it depends on your history.
• How do I switch from Saxenda to Wegovy or Ozempic?
  Because Saxenda is taken daily and semaglutide weekly, administer the first 0.25 mg semaglutide injection 24 hours after your last daily Saxenda dose.
• Can I use the same syringe units when switching compounded medications?
  Never. Syringe units depend on the specific concentration (mg/mL) prepared by the pharmacy. Always recalculate syringe units based on the new vial's concentration.

Use the free interactive calculator on GLPme →

GLPme is 100% free and on-device private on iPhone. No accounts, no paywalls.

Missed your Wegovy, Ozempic, Zepbound or Mounjaro dose? See what the FDA label says for your specific gap, including the catch-up window and when to contact your prescriber.

Frequently Answered Clinical Questions:

• I missed my Wegovy dose by 3 days. Can I still take it?
  The label says a missed semaglutide dose can be taken within 5 days of when it was due, then the normal schedule resumes. Confirm with your prescriber, especially if it has happened more than once.
• How long can I be late with a Zepbound dose?
  The tirzepatide label gives a 4 day catch-up window. Past that it says skip the dose and resume on your regular day. Doses should stay at least 3 days apart.
• What happens if I miss two weeks of my GLP-1?
  The label directs you to your prescriber. Two or more consecutive missed weekly doses commonly means restarting at a lower dose and re-titrating, because tolerance fades during the gap.
• Can I take two doses to catch up on a missed one?
  No GLP-1 label says to double up. It stacks drug on top of what is still circulating from the last dose, which is the most reliable way to produce severe nausea and vomiting.

Use the free interactive calculator on GLPme →

GLPme is 100% free and on-device private on iPhone. No accounts, no paywalls.

Free GLP-1 tapering calculator: personalized step-down schedules for Mounjaro, Ozempic, Zepbound & Wegovy. Calculate dose reductions, interval stretching (7-14 days), and half-life washout curves.

30-Second Clinical Verdict: Stopping a GLP-1 medication abruptly ("cold turkey") triggers a rapid rebound in appetite, food noise, and gastric emptying speed within 10 to 21 days. In clinical trial extensions (STEP-1 for semaglutide, SURMOUNT-4 for tirzepatide), patients discontinuing without a structured maintenance protocol regained approximately two-thirds (66%) of lost weight within 12 months . A structured step-down titration (reducing dose by one step every 2–4 weeks) or interval stretching (spacing shots from 7 to 10 or 14 days) allows the gut-brain axis to adapt gradually while you establish permanent nutritional and resistance-training baselines.

Frequently Answered Clinical Questions:

• Can I just stop Mounjaro or Ozempic cold turkey?
  While stopping cold turkey does not cause physical drug withdrawal like opioids or alcohol, it causes rapid rebound hunger and intense food noise within 2 to 3 weeks as the medication clears. Studies show patients who stop abruptly regain approximately two-thirds of their lost weight within a year. A structured taper significantly eases this transition.
• How does interval stretching (spacing doses 10 to 14 days apart) work?
  Because tirzepatide has a 5-day half-life and semaglutide has a 7-day half-life, spacing injections to every 10 or 14 days allows the drug blood concentration to drop lower during the trough while still blunting severe hunger spikes. It is an effective way to test whether your endogenous satiety cues can sustain weight stability with minimal drug support.
• What if my hunger returns fiercely during a dose step-down?
  If uncontrollable hunger or binge urges recur when stepping down (e.g. from 10 mg to 7.5 mg), clinical consensus is to hold at your current step for an extra 4 weeks or return to the prior dose. Many patients discover their minimum effective maintenance threshold (often 5.0 mg for tirzepatide or 0.5 mg for semaglutide) and choose to stay there long term.
• How long does it take for the medication to completely leave my system?
  It takes approximately 4 to 5 half-lives for a drug to reach less than 3% circulating concentration. For tirzepatide (~5 day half-life), clearance takes roughly 25 days. For semaglutide (~7 day half-life), clearance takes roughly 35 days.

Use the free interactive calculator on GLPme →

GLPme is 100% free and on-device private on iPhone. No accounts, no paywalls.

Free GLP-1 half-life calculator for semaglutide, tirzepatide and liraglutide. See the percentage remaining after any number of days, the five half-life clearance point, and how long a dose change takes to reach steady state.

Frequently Answered Clinical Questions:

• How long does semaglutide stay in your system?
  Semaglutide has an elimination half-life of about one week, so roughly 97% is cleared around five weeks after the final dose. Appetite and food-noise effects usually fade well before the drug is fully eliminated.
• What is the half-life of tirzepatide?
  About 120 hours, or roughly five days. Five half-lives is approximately 25 days, which is the usual working answer for when it is functionally cleared.
• How long does a GLP-1 dose increase take to take full effect?
  Around four to five half-lives of consistent dosing to reach steady state: four to five weeks for semaglutide and three to four weeks for tirzepatide. This is one reason titration steps are spaced four weeks apart.

Use the free interactive calculator on GLPme →

GLPme is 100% free and on-device private on iPhone. No accounts, no paywalls.

Free GLP-1 supply calculator. Work out how many doses are in your vial, when it runs out, and when to reorder, including a planned titration increase partway through.

Frequently Answered Clinical Questions:

• How many doses are in a 10 mg vial of compounded semaglutide?
  At 2.5 mg per injection, four doses. At 5 mg, two. If your dose steps up partway through the vial, count each dose level separately, because the total is not a simple division.
• When should I reorder my GLP-1 prescription?
  Work back from your run-out date by your pharmacy's real lead time, including any prior authorisation. Ten days is a common minimum, and shortages make it considerably longer.
• How long does a compounded vial last after opening?
  The beyond-use date on your label governs, commonly 28 days after first puncture. If the vial holds more doses than that window allows, the date is your limit rather than the medication remaining.
• Why did my vial run out a dose early?
  Some volume stays in the syringe hub and the vial on every draw. Across several doses that adds up to a fraction of a dose, so a vial that should hold four sometimes yields three and a bit.

Use the free interactive calculator on GLPme →

GLPme is 100% free and on-device private on iPhone. No accounts, no paywalls.

Free GLP-1 eligibility checker. Enter your height, weight and health conditions to see which FDA label criteria you meet for Wegovy, Zepbound, Saxenda, Ozempic and Mounjaro.

Frequently Answered Clinical Questions:

• What BMI do you need to qualify for Wegovy?
  A BMI of 30 or above on its own, or a BMI of 27 or above together with at least one weight-related condition such as type 2 diabetes, high blood pressure, obstructive sleep apnea, high cholesterol or heart disease. Those are the adult criteria on the label.
• Can I get Wegovy without diabetes?
  Yes. Wegovy is a weight-management medication and does not require diabetes. Type 2 diabetes is only one of several conditions that lets you qualify at a BMI of 27 to 29.9 instead of 30.
• Can I get Ozempic just for weight loss?
  Not under the label. Ozempic is approved to improve blood sugar in adults with type 2 diabetes. It contains semaglutide, the same molecule as Wegovy, so a prescriber treating weight rather than blood sugar will normally point you at Wegovy.
• I meet the BMI criteria but my insurance denied it. Why?
  Insurers set their own rules on top of the FDA label. Common ones are a higher BMI floor, proof of a documented supervised weight-loss attempt, a prior authorisation, or a plan that excludes weight-loss medication entirely. A denial does not mean you failed the label criteria.
• Does my BMI have to stay above 30 to keep the prescription?
  That is a plan-by-plan question rather than a label question. Some insurers reassess coverage as your BMI falls, and some require continued documented weight loss to keep authorising refills. Ask your prescriber to check the continuation criteria before you start, not after.

Use the free interactive calculator on GLPme →

GLPme is 100% free and on-device private on iPhone. No accounts, no paywalls.

Free protein calculator for people on Wegovy, Zepbound, Ozempic or Mounjaro. Get a daily protein target in grams and an even per-meal split to protect lean mass during weight loss.

Frequently Answered Clinical Questions:

• How much protein should I eat on Wegovy?
  While actively losing weight, most adults land between 1.6 and 2.0 grams per kilogram of body weight per day, which is roughly 0.7 to 0.9 grams per pound. A 200 lb adult doing some training is usually around 160 to 180 grams a day. Sedentary and weight stable sits closer to 1.2 grams per kilogram.
• Does Wegovy cause muscle loss?
  Any weight loss costs some lean mass. In the STEP 1 body composition substudy about 40% of the weight lost was lean mass, while the proportion of lean mass in the body went up because fat came off faster. The risk comes from the size of the calorie deficit and low protein intake, not from the drug directly. Protein plus resistance training is what changes the ratio.
• I cannot eat enough protein on semaglutide. What do I do?
  Eat the protein on your plate first, before anything else, since you will often stop eating part way through. Use liquid protein when solid food will not go down, such as a shake or a high protein yoghurt drink. Front-load the day, because appetite is usually worst in the evening, and injection day is usually the worst day of the week.
• Do protein shakes count toward the target?
  Yes. Whey, casein and soy are all complete proteins and count fully. Shakes are often the most practical option on a GLP-1 because liquid gets past the fullness that stops you finishing a meal. Check the label rather than the front of the tub, since some products sold as protein shakes are mostly carbohydrate.
• Is 100 grams of protein a day enough on a GLP-1?
  It depends entirely on your weight. At 60 kg and actively losing, 100 grams is a reasonable target. At 100 kg it is well short, roughly half of what the lean-mass literature supports during weight loss. Run your own numbers rather than using a round figure from a forum.

Use the free interactive calculator on GLPme →

GLPme is 100% free and on-device private on iPhone. No accounts, no paywalls.

Free GLP-1 cost calculator. Work out monthly and annual cost for Wegovy, Zepbound, Ozempic or Mounjaro, brand or compounded, and see the cost per pound lost using published trial averages.

Frequently Answered Clinical Questions:

• How much does Wegovy cost per month?
  List price is roughly $1,300 a month in the US. Manufacturer direct programs and savings cards bring the effective price down substantially for people who qualify, so enter what you actually pay.
• Is compounded semaglutide cheaper than Wegovy?
  Per month, almost always. Per pound lost, it depends on whether you stay on it for the same duration, because the loss curve is what converts spend into result.
• How much weight will I lose in a year on tirzepatide?
  SURMOUNT-1 reported about 20.9% of body weight at 72 weeks on 15 mg. Loss is front-loaded, so most of it happens in the first half of that period. Individual results ranged widely.
• Does the cost include everything?
  No. This is the medication only. Appointments, labs, syringes and shipping are real costs and are not included, so check what any subscription price actually covers.

Use the free interactive calculator on GLPme →

GLPme is 100% free and on-device private on iPhone. No accounts, no paywalls.

Free GLP-1 weight loss projection calculator. See a month-by-month estimate of your weight on Wegovy, Zepbound, Ozempic or Mounjaro, based on published trial averages.

Frequently Answered Clinical Questions:

• How much weight will I lose on tirzepatide?
  In SURMOUNT-1, participants on 15 mg tirzepatide lost about 20.9% of body weight on average at 72 weeks. Individual results ranged widely above and below that.
• How much weight will I lose on semaglutide?
  In STEP 1, participants on 2.4 mg semaglutide lost about 14.9% of body weight on average at 68 weeks.

Use the free interactive calculator on GLPme →

GLPme is 100% free and on-device private on iPhone. No accounts, no paywalls.

Interactive GLP-1 restaurant order guide for Ozempic, Wegovy, Mounjaro, and Zepbound. Safe, high-protein, low-fat orders for Chipotle, Chick-fil-A, Cava, Starbucks, Sweetgreen, and Panera.

Frequently Answered Clinical Questions:

• Why does restaurant food cause nausea on Ozempic or Mounjaro?
  GLP-1 medications substantially slow down gastric emptying. High-fat restaurant dishes (fried batter, creamy sauces, cheese, dressings) take 8 to 12 hours to leave the stomach, triggering acid reflux, sulfur burps, severe nausea, and vomiting. Sticking to grilled proteins with under 15g of added fat allows normal stomach motility.
• How do I hit 30 grams of protein dining out without getting sick?
  Double up on lean grilled poultry (grilled chicken at Chipotle or Cava, 12-count grilled nuggets at Chick-fil-A, or filet mignon at a steakhouse). Eat your protein first before touching any rice, bread, or carbohydrates, because stomach capacity is limited.
• What is the single most common mistake when dining out on a GLP-1?
  Drinking large cups of ice water or soda during the meal. Ingesting large volumes of fluid stretches already-slowed stomach walls, inducing immediate fullness and nausea. Drink your fluids 30 minutes before or after your meal.

Use the free interactive calculator on GLPme →

GLPme is 100% free and on-device private on iPhone. No accounts, no paywalls.

The honest answer has three parts: what the trials proved, what regulators are still watching, and the corner of the market where nearly all the documented harm is actually happening.

30-Second Clinical Verdict: For FDA-approved GLP-1 medications taken as directed, the clinical safety profile is backed by robust long-term data: the landmark 17,604-patient SELECT trial proved semaglutide 2.4 mg delivered a 20% relative reduction in major adverse cardiovascular events (heart attack, stroke, CV death). While common side effects are gastrointestinal (nausea 44%, diarrhea 30%), fewer than 2% discontinued therapy because of them. Serious risks like pancreatitis (~0.2%) remain rare. The single largest source of documented GLP-1 harm over the last 2 years was compounding syringe dosing errors, not the active molecule.

Key Clinical Questions Answered:

• Are GLP-1 medications safe long term?
  The longest high-quality safety data on the obesity dose comes from the SELECT trial, which followed 17,604 adults for a mean of 39.8 months without a safety finding that changed the recommendation. GLP-1 receptor agonists as a class have been prescribed for type 2 diabetes since 2005. Data beyond a decade at the 2.4 mg dose does not yet exist.
• Do GLP-1 drugs cause thyroid cancer?
  No human causal link has been established. The boxed warning exists because semaglutide caused dose-dependent thyroid C-cell tumours in rodents at clinically relevant exposures, and the label states that human relevance is unknown. It is contraindicated if you or a close relative has had medullary thyroid carcinoma or MEN 2.
• Is compounded semaglutide as safe as Ozempic or Wegovy?
  It is a different safety question. Approved products have a known identity, purity and concentration. The FDA has documented compounded-vial dosing errors of five to twenty times the intended dose, plus the use of unapproved salt forms such as semaglutide sodium and semaglutide acetate. Verify the concentration on every individual vial.
• What GLP-1 symptoms should I not ignore?
  Severe persistent abdominal pain radiating to the back, vomiting you cannot stop for more than 24 hours, sudden vision loss or rapidly worsening eyesight, signs of an allergic reaction, and low blood sugar symptoms if you also take insulin or a sulfonylurea.
• Do I need to tell my anaesthetist I take a GLP-1?
  Yes, including for dental sedation and endoscopy. Delayed gastric emptying means the stomach may not be empty after a standard fast, which is an aspiration risk under sedation.
• Does the weight come back if I stop a GLP-1?
  For most people a large share returns. In the STEP 1 trial extension, participants regained about two-thirds of their lost weight in the year after stopping, and cardiometabolic improvements moved back toward baseline.

Read the full clinical protocol on GLPme →

Side effects on Ozempic, Wegovy, Mounjaro and Zepbound follow a schedule. Here is when each one usually shows up, what reduces it, and the short list that means stop reading and call someone.

30-Second Clinical Verdict: GLP-1 side effects are predominantly gastrointestinal and dose-dependent: nausea affects 44% of semaglutide patients and 30% of tirzepatide patients in clinical trials, but under 2% stop treatment because of it. Symptoms concentrate within 24 to 72 hours following each weekly injection and flare during 4-week dose increases. Most side effects subside as the body adapts over 2 to 4 weeks at a stable dose. Seek same-day emergency medical care for severe abdominal pain radiating to the back (pancreatitis sign) or intractable vomiting preventing fluid retention.

Key Clinical Questions Answered:

• How long do GLP-1 side effects last?
  For most people gastrointestinal symptoms ease within two to four weeks at a stable dose, then return briefly after each dose increase. Constipation is the most likely to persist. Severe symptoms after several weeks at an unchanged dose should be reviewed by a prescriber.
• Which day after a GLP-1 injection is worst?
  Most people report days one to three after the shot as the peak window for nausea and fatigue, with day zero often quiet and days six to seven the trough, when appetite and food noise often return.
• Do side effects mean the medication is working?
  No. Side effect severity does not track with weight loss. People with mild symptoms often have strong results, and the reverse is equally common.
• Why am I so tired on a GLP-1?
  The most common cause is that calorie and protein intake fell further than intended when appetite dropped. Check protein against a target first. Persistent fatigue at a stable dose with adequate intake deserves investigation.
• What GLP-1 side effects are emergencies?
  Severe abdominal pain radiating to the back, vomiting you cannot stop for over 24 hours, sudden vision loss, a distended abdomen with no bowel movement, facial or throat swelling, and hypoglycaemia symptoms if you also take insulin or a sulfonylurea.

Read the full clinical protocol on GLPme →

The medication has a 17,604-person outcomes trial behind it. Some of what is being sold alongside it has nothing behind it at all. Here is how to tell which is which in about ninety seconds.

30-Second Clinical Verdict: The active medications semaglutide and tirzepatide are NOT a scam; they represent breakthrough pharmacology backed by multi-year double-blind trials demonstrating 15% to 22% weight reduction and 20% lower cardiovascular risk. However, the commercial industry surrounding them contains predatory practices: unvetted gray-market "research peptides," deceptive monthly subscription traps ($50–$100/mo platform fees with minimal clinician contact), and fake "natural GLP-1" supplement pills. Furthermore, obesity is a chronic condition: discontinuing treatment without an off-ramp leads to regaining roughly two-thirds of lost weight within a year.

Key Clinical Questions Answered:

• Are GLP-1 medications a scam?
  No. Semaglutide and tirzepatide have phase 3 randomised trial evidence and approval from the FDA, EMA and MHRA, and the SELECT trial followed 17,604 people for a mean of 39.8 months. Suspicion usually attaches to pricing, the grey market in unregulated vials, and telehealth subscription models rather than to the medication itself.
• Is it a scam that you regain the weight after stopping?
  The regain is real and documented at roughly two-thirds of lost weight within a year in the STEP 1 trial extension, but it was published by the trial programme itself. It reflects obesity behaving as a chronic condition. The legitimate complaint is that many people were never told before starting.
• Is compounded semaglutide legitimate?
  It depends on the source. A licensed compounding pharmacy filling a prescription differs from a website shipping research-chemical vials. The FDA has documented unapproved salt forms and warned about patients injecting five to twenty times the intended dose.
• Do natural GLP-1 supplements work?
  Not in any way comparable to GLP-1 receptor agonists. Products marketed as natural Ozempic alternatives, including berberine, are not GLP-1 receptor agonists and have no trial evidence approaching semaglutide's.
• How do I spot a bad telehealth GLP-1 provider?
  Ask for the exact product name and concentration in writing before paying, check whether dose increases are reviewed by a clinician or applied automatically on a calendar, and confirm there is a route to a human about side effects. Refusing to name the product is the clearest red flag.

Read the full clinical protocol on GLPme →

They were compared directly, over 72 weeks, in 751 people. Tirzepatide won on weight by 6.5 percentage points. Semaglutide still has one thing tirzepatide does not.

30-Second Clinical Verdict: The main difference between semaglutide and tirzepatide is biological mechanism and weight reduction potency. Tirzepatide is a dual GIP/GLP-1 receptor agonist that achieved 20.2% mean body weight reduction versus semaglutide's 13.7% in the 72-week head-to-head SURMOUNT-5 trial. However, semaglutide holds an established FDA-approved indication for major cardiovascular risk reduction (20% lower heart attack and stroke risk from the 17,604-patient SELECT trial) that tirzepatide has not yet matched.

Key Clinical Questions Answered:

• Is tirzepatide better than semaglutide?
  For weight reduction the head-to-head evidence says yes: 20.2% versus 13.7% over 72 weeks in SURMOUNT-5. For proven cardiovascular event reduction semaglutide currently has evidence tirzepatide does not, from the 17,604-person SELECT trial.
• Can I switch from semaglutide to tirzepatide?
  Yes, but it is not a milligram-for-milligram conversion. They are different molecules with different dose ladders and switching usually means re-titrating from the starting dose. It is a prescriber decision.
• Which has fewer side effects, semaglutide or tirzepatide?
  The profiles are similar in kind, mostly gastrointestinal and mostly during escalation. In SURMOUNT-5 fewer people stopped tirzepatide over them, 2.7% against 5.6%.
• Is 15 mg of tirzepatide equivalent to 2.4 mg of semaglutide?
  No. Different molecules, non-comparable milligram scales. Both are the top of their own approved ladder for weight management, which is the only sense in which they correspond.

Read the full clinical protocol on GLPme →

Identical molecule, different licence, different maximum dose — and that last difference is the one that decides what your insurance pays.

30-Second Clinical Verdict: Are Ozempic and Wegovy the same thing? Both contain the exact same chemical molecule (semaglutide) manufactured by Novo Nordisk with identical biological mechanisms. However, they differ in three key areas: FDA indication (Ozempic for type 2 diabetes vs Wegovy for obesity), maximum dose (2.0 mg for Ozempic vs 2.4 mg for Wegovy), and insurance coverage (insurers routinely cover diabetes but frequently exclude obesity medications). Prescribing Ozempic for weight loss is legally off-label.

Key Clinical Questions Answered:

• Are Ozempic and Wegovy the same drug?
  Yes. Both contain the identical active molecule (semaglutide) manufactured by Novo Nordisk. They differ in licensed indication (diabetes vs obesity), delivery device, and maximum dosage (2.0 mg vs 2.4 mg).
• Is Wegovy stronger than Ozempic?
  Yes, at the top dose. Wegovy escalates to a maximum maintenance dose of 2.4 mg weekly, whereas Ozempic stops at 2.0 mg. The large STEP weight loss trials were conducted at 2.4 mg.
• Is Ozempic the same as Wegovy?
  Same active ingredient, semaglutide, same manufacturer. They differ in licensed indication and maximum dose: Ozempic for type 2 diabetes up to 2 mg, Wegovy for weight management up to 2.4 mg.
• Which is better for weight loss, Ozempic or Wegovy?
  Wegovy is the licensed weight-management product and reaches 2.4 mg, the dose used in the STEP weight-loss trials and the SELECT cardiovascular trial. Ozempic stops at 2 mg.
• Can I take Ozempic for weight loss if insurance denies Wegovy?
  Prescribing Ozempic for weight loss is common off-label use. While pharmacologically effective, it caps at 2.0 mg, and insurers may require a type 2 diabetes diagnosis.
• Can I switch from Ozempic to Wegovy?
  It is the same molecule, so switching is usually simpler than moving between different drugs, but the landing dose and whether you re-titrate are prescriber decisions.
• Why does insurance cover Ozempic but not Wegovy?
  Insurers price by licensed indication rather than by molecule. Coverage for type 2 diabetes and coverage for weight management are separate decisions even when the drug is identical.

Read the full clinical protocol on GLPme →

Same molecule, same ladder, same 15 mg ceiling. Unlike Ozempic and Wegovy there is no dose difference here at all — which makes coverage the only real question.

30-Second Clinical Verdict: The main difference between Mounjaro and Zepbound is FDA indication and insurance approval, not the drug itself. Both contain the exact same active molecule (tirzepatide), manufactured by Eli Lilly, climbing the identical dose ladder from 2.5 mg up to 15 mg weekly. Mounjaro is FDA-licensed for type 2 diabetes, while Zepbound is approved for chronic weight management and obstructive sleep apnea. Switching between them is a coverage and billing change rather than a clinical one.

Key Clinical Questions Answered:

• Is Mounjaro the same as Zepbound?
  Yes. Both are tirzepatide from the same manufacturer with the same dose ladder to the same 15 mg maximum. Mounjaro is licensed for type 2 diabetes, Zepbound for weight management and for obstructive sleep apnoea with obesity.
• Is Mounjaro or Zepbound stronger?
  Neither. Unlike Ozempic and Wegovy, where maximum doses differ, these share an identical ladder and an identical 15 mg ceiling.
• Can I switch between Mounjaro and Zepbound?
  Clinically it is the same molecule at the same dose, so switching is usually straightforward, but it remains a prescribing decision and is normally driven by coverage rather than effect.
• Which is better for weight loss?
  Zepbound is the licensed weight-management product, which matters for coverage and for the approved 5, 10 and 15 mg maintenance options. The molecule and doses are the same.

Read the full clinical protocol on GLPme →

Head-to-head clinical trial results (SURMOUNT-5), mechanism differences (GLP-1 vs dual GIP/GLP-1), SELECT cardiovascular data, monthly costs, and switching protocols.

30-Second Clinical Verdict: The main difference between Wegovy and Zepbound is that Wegovy (semaglutide 2.4 mg) is a selective GLP-1 agonist with ~15% trial weight loss and proven cardiovascular MACE reduction (SELECT trial), while Zepbound (tirzepatide 15 mg) is a dual GIP/GLP-1 agonist with ~21% trial weight loss and superior head-to-head reduction in SURMOUNT-5 (20.2% vs 13.7%). Zepbound delivers significantly higher total weight loss, greater waist reduction, and lower GI discontinuation (2.7% vs 5.6%), whereas Wegovy carries an established FDA indication for reducing heart attack and stroke risk. Both list around $1,059–$1,349/month, though compounded alternatives cost $178–$399/month.

Key Clinical Questions Answered:

• Is Zepbound stronger than Wegovy?
  Yes, in terms of weight loss. In the 72-week SURMOUNT-5 trial, Zepbound (tirzepatide) achieved 20.2% mean body weight loss compared to 13.7% for Wegovy (semaglutide). Zepbound activates both GIP and GLP-1 receptors, while Wegovy targets GLP-1 alone.
• Can I switch from Wegovy to Zepbound if I hit a weight loss plateau?
  Yes, switching between the two is common under medical supervision. You must wait 7 days after your last Wegovy dose and re-titrate starting from a lower dose (typically 2.5 mg or 5 mg) rather than jumping straight to 15 mg.
• Why did Zepbound beat Wegovy in the SURMOUNT-5 trial?
  Zepbound is a dual GIP/GLP-1 receptor agonist. Adding GIP receptor activation improves insulin sensitivity in adipose tissue and acts synergistically with GLP-1 in the brain to suppress appetite and increase energy expenditure beyond what GLP-1 alone achieves.
• Does Wegovy have any advantages over Zepbound?
  Yes. Wegovy has proven cardiovascular protection from the 17,604-patient SELECT trial (20% reduction in heart attack, stroke, and CV death) and holds an official FDA indication for cardiovascular risk reduction.
• Why is Zepbound cheaper than Wegovy?
  Brand Zepbound lists at ~$1,059/month versus Wegovy's ~$1,349/month, and LillyDirect offers 2.5 mg and 5.0 mg single-dose self-pay vials ($399 and $549/month). Out-of-pocket costs ultimately depend on insurance formulary coverage.
• Which drug causes worse nausea and stomach side effects?
  In SURMOUNT-5, gastrointestinal discontinuation favored Zepbound: 2.7% stopped tirzepatide due to GI side effects compared to 5.6% on semaglutide. GIP co-activation appears to moderate nausea intensity.
• Can I stay on a low dose of Zepbound for maintenance?
  Yes. Zepbound is FDA-approved for maintenance at 5 mg, 10 mg, or 15 mg. Wegovy is officially indicated for 2.4 mg maintenance (with 1.7 mg allowed only if 2.4 mg is intolerable).
• What should I do if insurance denies both Wegovy and Zepbound?
  Options include filing an insurance appeal with a letter of medical necessity, manufacturer copay savings cards, LillyDirect cash vials, or legitimate 503A/503B compounded pharmacies ($178–$399/mo).

Read the full clinical protocol on GLPme →

Delayed gastric emptying means a standard fast may not have emptied your stomach. The guidance changed in 2024, and almost nobody has been told.

30-Second Clinical Verdict: Always disclose your GLP-1 medication to your anesthesia team before any procedure requiring sedation. Because GLP-1 agonists slow gastric emptying, residual food can remain in the stomach despite an 8-hour overnight fast, creating a serious pulmonary aspiration hazard. Under updated 2024–2026 multi-society guidance, patients without gastrointestinal symptoms often do not need to withhold weekly injections, but must follow a 24-hour liquid-only fast prior to surgery. If you have active nausea or reflux, surgical protocols recommend withholding weekly doses for 7 days before general anesthesia.

Key Clinical Questions Answered:

• Do I need to stop my GLP-1 before surgery?
  Not necessarily. The October 2024 multi-society guidance says most patients without significant gastrointestinal symptoms can continue their GLP-1 and instead fast from solid food for 24 hours with clear liquids only. Higher-risk patients are managed individually. Follow your own team's protocol.
• Why does taking a GLP-1 matter for anaesthesia?
  Slowed gastric emptying is part of how the drug works, so the stomach may still contain food after a standard overnight fast. Under sedation the reflexes that keep stomach contents out of the airway are suppressed, making that an aspiration risk.
• How long should I fast from solid food before surgery on a GLP-1?
  Current multi-society guidance is 24 hours of clear liquids only before a procedure requiring anaesthesia, for patients without significant GI symptoms.
• Do I need to tell my dentist I take a GLP-1?
  Yes, if any sedation is involved. The risk follows the depth of sedation rather than the seriousness of the procedure.
• Who is higher risk for delayed gastric emptying before a procedure?
  People in the dose escalation phase, on weekly dosing, on higher doses, or with current gastrointestinal symptoms.

Read the full clinical protocol on GLPme →

People kept reporting they wanted a drink less. A randomised trial went and tested it. Here is what it found, and the separate practical question of drinking on a slowed stomach.

30-Second Clinical Verdict: There is no direct chemical interaction between GLP-1 medications and alcohol, but combining them introduces three distinct clinical risks: severe dehydration and nausea, impaired hepatic gluconeogenesis increasing hypoglycemia danger (especially in diabetes), and unpredictable intoxication curves due to delayed stomach emptying. Notably, clinical trials demonstrate that semaglutide dampens dopamine-mediated reward pathways in the brain, causing many patients to spontaneously lose cravings for alcohol entirely.

Key Clinical Questions Answered:

• Can you drink alcohol on Ozempic or Wegovy?
  There is no direct drug interaction, but alcohol can affect you differently on a slowed stomach, compounds dehydration when nausea is present, and raises hypoglycaemia risk if you also take insulin or a sulfonylurea.
• Do GLP-1 medications reduce alcohol cravings?
  A randomised phase 2 trial of 48 adults with alcohol use disorder found low-dose semaglutide significantly reduced weekly alcohol craving and reduced drinking on several measures over nine weeks. No GLP-1 is approved to treat alcohol use disorder.
• Does alcohol stop GLP-1 weight loss?
  It does not block the drug, but it is a common cause of a plateau appearing without any change in eating: uncounted calories, disinhibited food choices afterwards, and disrupted sleep.
• Why does alcohol feel stronger on a GLP-1?
  Slowed gastric emptying changes how fast alcohol reaches the bloodstream, and reduced food intake means there is often less in the stomach to slow absorption.

Read the full clinical protocol on GLPme →

Most plateaus are not plateaus, and most real ones have a boring, fixable cause. Here is the checklist, in the order worth checking it.

30-Second Clinical Verdict: A true weight-loss plateau on GLP-1 therapy is defined as 4 consecutive weeks with zero change in moving 7-day average weight or body measurements at a stable dose. Stalls occur primarily from metabolic adaptation (your shrinking body requires fewer daily maintenance calories), gradual portion drift as gastrointestinal tolerance develops, or reaching your individual biological set-point. STEP-1 and SURMOUNT-1 trials show weight loss naturally stabilizes around weeks 60 to 68; never increase your dose without clinician approval.

Key Clinical Questions Answered:

• Why has my weight loss stopped on Ozempic or Wegovy?
  The most common causes are that the dose is still escalating, protein and portion sizes have drifted, alcohol has returned, or sleep has dropped. Weight also naturally plateaus as you approach a new equilibrium — the trial curves flatten too.
• How long is a normal GLP-1 plateau?
  Under two weeks of a flat seven-day average is noise. Four or more weeks at a stable dose with unchanged intake is worth raising with a prescriber.
• Should I increase my dose if I plateau?
  Not on your own. Titration schedules exist because escalating too quickly drives nausea, vomiting and dehydration. A plateau is a reason to ask about a review, not to self-adjust.
• Does GLP-1 medication stop working over time?
  A flattening curve is expected as you approach a new equilibrium and is not the same as losing effect. A flat seven-day average for a month at a stable dose with unchanged intake is the point to have it assessed.

Read the full clinical protocol on GLPme →

Real, reported in the trials, and in almost every case temporary. The cause is the weight loss rather than the molecule — which is also why protein is the lever that matters.

30-Second Clinical Verdict: Hair shedding on Ozempic, Wegovy, or Zepbound is caused by telogen effluvium—a physiological reaction to rapid weight loss and severe caloric deficit, NOT direct drug toxicity. Reported in ~3% of clinical trial participants (versus 1% on placebo), shedding typically surfaces 2 to 4 months after rapid weight loss begins. The condition is temporary and self-limiting; hair shedding stops and follicles regrow within 3 to 6 months once weight stabilizes and adequate daily protein (1.2–1.6 g/kg) and ferritin levels are restored.

Key Clinical Questions Answered:

• Does Ozempic or Wegovy cause hair loss?
  Alopecia was reported in the Wegovy weight-management trials in roughly 3% of adults against about 1% on placebo, and European labelling classes it as common. The mechanism is thought to be telogen effluvium from rapid weight loss and reduced intake rather than a direct effect on follicles.
• Is GLP-1 hair loss permanent?
  In most cases no. Telogen effluvium is self-limiting and typically resolves within three to six months once the trigger settles, with regrowth following.
• When does hair loss start on a GLP-1?
  Usually two to four months after weight loss accelerates, because the shed hairs were pushed into the resting phase months earlier.
• How do I stop hair loss on a GLP-1?
  Meet a protein target, have iron, zinc and vitamin D checked if shedding is significant, and avoid pushing the rate of weight loss faster. Ask before supplementing.
• Should I stop my GLP-1 because of hair loss?
  That is a prescriber conversation. The shedding is usually temporary while the reasons for treatment usually are not; a slower rate of loss may address it without stopping.

Read the full clinical protocol on GLPme →

A U-100 syringe mark is a volume. The milligrams in that volume come from the vial in your hand. The FDA's compounding alerts are mostly this mix-up.

30-Second Clinical Verdict: Syringe units are a volume measurement (where 100 units = 1.0 mL on a standard U-100 syringe), NOT a medication dose in milligrams. The exact number of units you draw depends strictly on your vial's concentration: for semaglutide at 2.5 mg/mL, a 0.25 mg dose is 10 units ; at 5.0 mg/mL, that exact same dose is only 5 units . For tirzepatide at 10 mg/mL, 2.5 mg is 25 units ; at 20 mg/mL, it is 12.5 units . Never transfer syringe marks across different vial strengths.

Key Clinical Questions Answered:

• How many units is 2.5 mg of tirzepatide?
  It depends on the vial concentration. At 5 mg/mL, 2.5 mg is 50 units on a U-100 syringe. At 10 mg/mL it is 25 units.
• Can I use a U-40 syringe with these numbers?
  No. The site calculators assume U-100. A U-40 barrel is a different scale.
• Is there an iOS app that logs compounded doses in syringe units?
  Yes. GLPme natively supports compounded semaglutide and tirzepatide vial concentrations and syringe unit conversions.
• Is this telling me what dose to take?
  No. It converts a milligram dose you were already given into a syringe mark for a stated concentration.

Read the full clinical protocol on GLPme →

Rapid weight loss takes lean mass along with fat. What DXA trials show, exact daily protein targets, and the resistance training protocol to keep muscle.

30-Second Clinical Verdict: Rapid weight loss on GLP-1 medications typically consists of 25% to 40% lean mass reduction if resistance training and nutrition are neglected. In the STEP-1 DXA sub-study, 39% of total weight lost was lean body mass (~5.3 kg lean vs 8.4 kg fat). To protect skeletal muscle and maintain resting metabolic rate, clinical protocols mandate two daily non-negotiables: consuming 1.2 to 1.6 grams of protein per kilogram of body weight (25–35g per meal to stimulate muscle protein synthesis) and performing 2 to 3 weekly progressive resistance training sessions .

Key Clinical Questions Answered:

• Does Ozempic cause more muscle loss than other diets?
  No. Clinical trials show the proportion of lean mass lost is identical to other rapid caloric deficits.
• Should I take creatine while on Wegovy or Zepbound?
  Creatine monohydrate (3-5g daily) is safe and supports muscular strength retention.
• What happens to my metabolism if I lose muscle?
  Losing muscle lowers basal metabolic rate, making post-treatment weight maintenance harder.

Read the full clinical protocol on GLPme →

What compounded semaglutide and tirzepatide cost across major telehealth providers in 2026. Flat rates vs titration surcharges, and 503A vs 503B oversight.

Key Clinical Questions Answered:

• Does health insurance cover compounded GLP-1s?
  Rarely. Almost all commercial health plans exclude compounded weight loss medications.
• Why are compounded versions so much cheaper?
  Compounders do not bear drug development R&D, patent royalties, or auto-injector manufacturing costs.
• What supplies are included with compounded vials?
  Legitimate providers ship sterile U-100 insulin syringes and alcohol wipes with the medication.

Read the full clinical protocol on GLPme →

There is no Ozempic withdrawal syndrome — but appetite, food noise and, for people with diabetes, blood glucose all come back. Step-down tapering schedules, microdosing maintenance options, and the 2-week restart rule.

30-Second Clinical Verdict: There is no physical drug withdrawal syndrome when stopping Ozempic, but semaglutide clears gradually over 4 to 5 weeks (half-life of ~120 hours). As blood concentrations drop, appetite suppression and "food noise" typically rebound within 1 to 3 weeks. In the STEP-1 trial extension, participants who discontinued semaglutide without an ongoing maintenance plan regained approximately two-thirds (66%) of their lost weight within 12 months, accompanied by reversion of cardiometabolic improvements toward baseline. If prescribed for diabetes, blood glucose rises within weeks of stopping.

Key Clinical Questions Answered:

• How do I wean off Ozempic safely?
  Rather than quitting cold turkey from 1.0 mg or 2.0 mg, clinicians often recommend stepping down the dose ladder every 4 weeks (e.g. from 2.0 mg to 1.0 mg, then 0.5 mg, then 0.25 mg). This gradual descent cushions the digestive rebound and prevents immediate overeating.
• Can I microdose Ozempic for maintenance?
  Yes. Maintaining on 0.25 mg or 0.5 mg weekly or extending the injection interval to 10 days is a common maintenance approach that holds baseline satiety and insulin sensitivity while reducing side effects and medication expense.
• Can I restart Ozempic after stopping for more than 2 weeks?
  Yes, but you must start over at the 0.25 mg introductory dose. If you have been off Ozempic for more than 14 days, jumping back in at 1.0 mg or 2.0 mg causes severe vomiting and acute gastric distress because gastrointestinal tolerance has reset.
• What happens if you stop taking Ozempic?
  Appetite and food noise return as the drug clears, usually within one to three weeks, and weight typically follows. In the STEP 1 trial extension people regained about two-thirds of lost weight within a year. If you take it for type 2 diabetes, blood glucose also rises back toward its untreated level.
• Are there Ozempic withdrawal symptoms?
  Not in the medical sense. GLP-1 medications do not cause physical dependence and there is no withdrawal syndrome. What people experience is the return of appetite, food noise and higher blood glucose — the absence of a drug effect rather than a reaction to its removal.
• How long does Ozempic stay in your system?
  Semaglutide has an elimination half-life of about one week, so roughly 97% is cleared after about five weeks. The effects fade sooner, commonly within one to three weeks.
• Should I come off Ozempic once I reach my goal weight?
  That is a clinical decision. In STEP 4, people who continued semaglutide after a 20-week run-in lost a further 7.9% of body weight while those switched to placebo gained 6.9%. Ask about a maintenance dose before asking about a stop date.
• Can I take Ozempic every other week to make it last longer?
  Not as a self-managed decision. Dose stretching changes drug levels and side-effect risk and is usually driven by cost. If cost is the pressure, raise it directly, because that problem has named alternatives.

Read the full clinical protocol on GLPme →

Maintenance on Wegovy is a phase of treatment, not the end of it. What the maintenance dose is, what STEP 4 found about staying on versus stopping, and the signals that move before the scale does.

30-Second Clinical Verdict: Do you keep losing weight on the maintenance dose of Wegovy? Yes initially, but not forever. In the STEP-4 clinical trial, patients who reached the 2.4 mg maintenance dose lost an additional 7.9% between weeks 20 and 68 before weight loss stabilized. For the vast majority, the 2.4 mg maintenance dose acts as metabolic weight stabilization — holding your new set point and suppressing the severe ~67% rebound that occurs when treatment stops.

Key Clinical Questions Answered:

• What is the maintenance dose of Wegovy?
  2.4 mg once weekly, reached around week seventeen on the standard escalation. It is the dose used in the STEP weight-management trials and in the SELECT cardiovascular outcomes trial.
• Do you lose weight on the maintenance dose of Wegovy?
  In STEP 4, participants continuing at 2.4 mg lost an additional 7.9% of body weight between weeks 20 and 68 before weight stabilized. The maintenance dose initially extends weight loss, but its primary long-term biological function is defending your new set point.
• What is the Wegovy maintenance dose after reaching goal weight?
  The FDA-approved maintenance dose is 2.4 mg once weekly. Some clinicians step down to 1.7 mg or 1.0 mg for patients who maintain weight stability and wish to minimize side effects or cost, but stopping entirely triggers weight regain for two-thirds of patients.
• How long do you stay on Wegovy?
  It is licensed as long-term treatment for a chronic condition rather than a fixed course. The trial evidence is that continuing maintains the result and stopping largely reverses it.
• Can you maintain weight loss on a lower Wegovy dose?
  Some people do, but 2.4 mg is the licensed maintenance dose and where the maintenance evidence comes from. Lower-dose maintenance is a prescriber decision, not something to trial between appointments.
• Is a Wegovy plateau the same as maintenance?
  No. A plateau is weight loss stalling while you still expect to lose, often because the dose is still escalating or intake has drifted. Maintenance is weight holding by design at the maintenance dose.
• What happens if I stop Wegovy after reaching my goal weight?
  In STEP 4, people switched to placebo gained 6.9% over 48 weeks while those continuing lost a further 7.9%. In the STEP 1 extension about two-thirds of lost weight returned within a year of stopping.

Read the full clinical protocol on GLPme →

Tirzepatide clears faster than semaglutide and there is no withdrawal syndrome — but stopping abruptly triggers rapid regain. Step-down tapering schedules, microdosing maintenance protocols, and the 2-week restart rule.

30-Second Clinical Verdict: Tirzepatide has an elimination half-life of 5 days and takes approximately 25 to 30 days to clear your bloodstream. In the SURMOUNT-4 trial, patients who achieved 20.9% weight reduction at week 36 and were switched to placebo regained 14% of their body weight over the next 52 weeks, whereas patients maintained on tirzepatide lost an additional 5.5%. Discontinuing Mounjaro without a structured maintenance protocol (such as lower maintenance dosing or dose spacing) results in rapid return of food noise and loss of glycemic and cardiometabolic benefits.

Key Clinical Questions Answered:

• How do I wean off Mounjaro safely without gaining weight?
  Clinicians recommend a gradual reverse-titration step-down taper: reducing your weekly dose by 2.5 mg every 4 weeks (e.g. from 15 mg or 10 mg down to 7.5 mg, then 5 mg, then 2.5 mg). This cushions the hunger rebound, allows your digestive tract to readapt to normal gastric emptying speeds, and gives you time to lock in high-protein habits.
• Can you microdose Mounjaro for weight maintenance?
  Yes. Many patients maintain weight loss by microdosing 2.5 mg or 5.0 mg once weekly, or by spacing injections to every 10 to 14 days under physician guidance. Because tirzepatide has a 5-day half-life, 10-day spacing holds steady-state receptor coverage while reducing medication cost and side effects by 30% to 50%.
• What happens if I stop and restart Mounjaro after 2 weeks?
  If you have been off Mounjaro for more than 14 days, your physiological tolerance has reset. Restarting at a high maintenance dose (like 7.5 mg, 10 mg, or 15 mg) can cause severe gastrointestinal distress and vomiting. The FDA prescribing label advises re-titrating from the 2.5 mg starting dose.
• What happens when you stop taking Mounjaro?
  Appetite and food noise return as tirzepatide clears, typically over one to three weeks, and blood glucose rises back toward its untreated level. In SURMOUNT-4, most participants who withdrew regained 25% or more of the weight they had lost within a year.
• Is there Mounjaro withdrawal?
  No. Tirzepatide does not cause physical dependence and there is no withdrawal syndrome. What people describe as withdrawal is the return of appetite, food noise and higher blood glucose.
• How long does tirzepatide stay in your system?
  The elimination half-life is about 120 hours, roughly five days, so about 97% is cleared after around 25 days. Appetite effects fade considerably sooner.
• Is Mounjaro the same as Zepbound?
  Same molecule, different licensed indication: Mounjaro for type 2 diabetes, Zepbound for weight management. Coverage can differ between them for the same person.
• Can I switch from Mounjaro to Ozempic?
  Switching between tirzepatide and semaglutide is possible but is not a milligram-for-milligram swap. They are different molecules with different dose ladders and the switch usually involves re-titrating. It is a prescriber decision.

Read the full clinical protocol on GLPme →

Zepbound has three approved maintenance doses rather than one, so where you stay is an actual decision. What SURMOUNT-4 found about continuing, and what maintenance is really protecting.

30-Second Clinical Verdict: What is the Zepbound maintenance dose after reaching goal weight? Unlike Wegovy (which only approves 2.4 mg), Zepbound is FDA-approved for long-term maintenance at 5 mg, 10 mg, or 15 mg once weekly. After reaching your target weight, you do not have to escalate to or remain on 15 mg. The evidence-based clinical objective is selecting the lowest of these three maintenance tiers that keeps food noise quiet and preserves weight stability with minimal side effects.

Key Clinical Questions Answered:

• What is the maintenance dose of Zepbound?
  Zepbound is approved for maintenance at 5 mg, 10 mg or 15 mg once weekly. 2.5 mg is a starting dose, and 7.5 mg and 12.5 mg are escalation steps rather than approved maintenance doses.
• What is the Zepbound maintenance dose after reaching goal weight?
  After reaching goal weight, prescribers recommend either remaining on your current effective dose (5, 10, or 15 mg) or carefully stepping down to a lower approved maintenance tier to determine the lowest dose that maintains weight stability.
• Do you keep losing weight on the Zepbound maintenance dose?
  Weight loss slows and reaches a natural plateau between months 9 and 18 as the body reaches metabolic equilibrium. The maintenance dose then functions to defend your new set point.
• Do I have to reach 15 mg on Zepbound?
  No. Because Zepbound has three approved maintenance doses, staying at 5 or 10 mg is a legitimate destination if your result holds there with fewer side effects.
• What happens if I stop Zepbound?
  In SURMOUNT-4, most participants who withdrew after 36 weeks of tirzepatide regained 25% or more of the weight they had lost within a year, and cardiometabolic improvements reversed alongside it.
• Is Zepbound the same as Mounjaro?
  Same molecule, tirzepatide, with different licensed indications: Zepbound for weight management, Mounjaro for type 2 diabetes. Insurance coverage can differ between them.
• How do I keep muscle during Zepbound maintenance?
  Protein intake and resistance training are the two levers with consistent evidence. Both tend to slip once weight stops falling, which is when they matter most.

Read the full clinical protocol on GLPme →

How to order at major restaurant chains without acute nausea, sulfur burps, or wasting half your plate. Tested ordering blueprints, chain menus, and portion rules.

30-Second Clinical Verdict: Dining out on Ozempic, Wegovy, Mounjaro, or Zepbound is fully manageable if you adhere to three physiological rules. Because GLP-1 receptor agonists delay gastric emptying, high-fat, greasy, or deep-fried restaurant dishes sit in the stomach for hours, triggering acute nausea, sulfur burps, acid reflux, or vomiting. When ordering: (1) Box half immediately: ask for a to-go container as soon as the plate arrives to avoid overfilling a reduced-capacity stomach; (2) Prioritize 30g lean protein: eat grilled chicken, fish, sirloin, or tofu before touching carbohydrates; (3) Keep added fat under 15g: request dressings, oils, and heavy sauces strictly on the side.

Key Clinical Questions Answered:

• Can I order off the kids' menu at restaurants?
  Many casual dining restaurants allow adults to order from the children's or senior menu, especially if you explain you have medical portion restrictions. However, fast-casual customizable bowls or sharing an entree with a dining partner is often higher quality.
• Why does fried food make me feel so sick on Ozempic or Wegovy?
  Fat is the most potent natural inhibitor of stomach emptying. Because GLP-1 medications already slow stomach transit, high-fat greasy foods create gastric stasis, producing sulfur gas, intense nausea, and vomiting.
• What is the best fast food option on road trips?
  Chick-fil-A grilled chicken nuggets, In-N-Out protein-style double burgers without spread, or Starbucks sous-vide egg bites. At gas station stops, reach for beef jerky, string cheese, Greek yogurt, or hard-boiled eggs.
• How do I handle social pressure to finish my plate?
  A simple, polite response works best: 'The food is delicious, but my appetite is small tonight. I am saving the rest for lunch tomorrow.' Having the server box the food right away eliminates awkward plate-checking.

Read the full clinical protocol on GLPme →

When severe appetite suppression makes eating feel impossible, you still need 100g+ of daily protein to protect lean muscle. 10 rapid, gentle, 30g-protein meal blueprints.

30-Second Clinical Verdict: When severe appetite suppression eliminates food noise, eating large volumes of food becomes physically impossible. To prevent losing 25% to 40% of your weight as lean skeletal muscle, you must shift from low-calorie high-volume dieting to high-density, low-volume nutrition . Each meal should deliver at least 25 to 35 grams of high-quality protein (providing the 2.5g leucine trigger for muscle protein synthesis) in less than 300 to 450 calories, with zero greasy or heavily acidic components that aggravate delayed gastric emptying.

Key Clinical Questions Answered:

• Why does protein make me feel full so quickly on a GLP-1?
  Protein is the most satiating macronutrient, stimulating endogenous peptide YY (PYY) and CCK release. Combined with medication, a 30g serving creates profound satiety.
• Are protein bars a good choice on Ozempic or Zepbound?
  Use caution. Many commercial bars contain sugar alcohols (erythritol, maltitol) or inulin fiber that ferment in a slowed GI tract, triggering severe cramping and diarrhea.
• What if I cannot physically finish a 30g protein meal?
  Do not force it to the point of nausea. Stop eating, wait 60–90 minutes, and finish the remainder, or switch to clear whey isolate drinks that absorb without solid bulk.
• Should I take digestive enzymes with meals?
  Many patients find broad-spectrum digestive enzymes taken with protein help accelerate food breakdown, reducing the sensation of food sitting heavy in the stomach.

Read the full clinical protocol on GLPme →

Where to find real patient titration experiences, side-effect solutions, and peer support without sponsored telehealth ads or peptide scams. Vetted subreddits and forums.

30-Second Clinical Verdict: Peer support communities are the single most valuable resource for real-world GLP-1 titration advice, side-effect management, and insurance navigation. Because prescribers rarely have time to explain food noise rebound, compounding vial math, or pharmacy supply shortages, over 500,000 active patients rely on peer forums daily. However, unmoderated groups carry significant risks: unregulated peptide sales, unverified medical advice, and aggressive telehealth affiliate shilling. Stick to verified, well-moderated Reddit subreddits and non-profit patient advocacy groups , and never purchase unverified medications from private direct messages.

Key Clinical Questions Answered:

• Are Reddit GLP-1 communities safe?
  Yes, the major subreddits are actively moderated by experienced volunteer teams who delete spam and illegal drug sales. However, peer advice should always supplement care from your licensed medical provider.
• Why are compounded medication discussions banned on some subreddits?
  Subreddits like r/Ozempic enforce rules focusing exclusively on FDA-approved commercial pens to prevent spam and liability. Dedicated communities permit compounding math.
• What should I do if a moderator removes my post?
  Check the sidebar and wiki. Most removals happen automatically because the question is answered in the FAQ or triggered an automated keyword filter.
• How do I find a local in-person support group?
  Ask your prescribing endocrinology or metabolic clinic. The Obesity Action Coalition also lists local regional chapters.

Read the full clinical protocol on GLPme →

What to buy when food noise is gone and heavy meals cause nausea. High-protein staples, ready-to-drink shakes, and gentle GI rescue items for Costco and Trader Joe's.

30-Second Clinical Verdict: Grocery shopping on a GLP-1 requires shifting away from high-volume diet foods toward compact, ultra-digestible protein staples and GI rescue items. During the initial 4 to 8 weeks, fatigue and sudden food aversions make cooking raw meat unappealing. Your cart needs three core pillars: (1) Ready-to-eat protein: Fairlife 30g shakes, rotisserie chicken breast, plain Greek yogurt, and hard-boiled eggs; (2) Gentle soluble fiber: blueberries, chia seeds, and peeled sweet potatoes (avoiding raw fibrous cruciferous vegetables); and (3) A 24/7 OTC GI toolkit: ginger chews, peppermint tea, unflavored electrolytes, and chewable simethicone for sulfur burps.

Key Clinical Questions Answered:

• How much should I spend on groceries while on a GLP-1?
  Most patients find their monthly grocery bill drops by 30% to 50% because portion sizes shrink and impulse snack purchases vanish. Reinvest in higher-quality lean protein.
• What if milk or dairy suddenly makes me nauseous?
  Delayed gastric emptying can induce transient secondary lactose intolerance. Switch to ultra-filtered lactose-free milk (Fairlife) or plant-based protein isolates.
• How many protein shakes should I drink per day?
  Aim for a maximum of 1 to 2 shakes daily. Use shakes to hit your daily protein floor, relying on whole foods (chicken, fish, eggs) for the remainder.
• What is the best bread or grain to buy?
  Sprouted grain bread (Ezekiel) or sourdough. Fermented sourdough is partially broken down by wild yeasts, making it significantly easier on slow digestion.

Read the full clinical protocol on GLPme →

How to navigate airport security, fly with pens and needles without confiscation, exact room-temperature stability limits, and what to eat in terminals.

30-Second Clinical Verdict: Traveling with Ozempic, Wegovy, Mounjaro, or Zepbound is straightforward once you know three non-negotiable rules: (1) Never check your pens: commercial airplane cargo holds routinely plunge below freezing (−40°F/−40°C). Freezing irreversibly denatures GLP-1 peptide chains, rendering the medication inactive and cloudy. Always pack pens and needles in your carry-on or personal item; (2) You probably don't need ice packs: unpunctured and in-use pens tolerate room temperature (up to 86°F / 30°C) for extended periods — Ozempic lasts 56 days, Wegovy lasts 28 days, and Mounjaro/Zepbound last 21 days. For trips under 3 to 4 weeks, packing a bulky medical cooler is unnecessary unless visiting extreme heat climates; (3) Keep the prescription box: TSA does not require an advance doctor's note for injectable pens, but having the original pharmacy carton displaying your legal name and Rx number resolves 99% of airport security queries instantly.

Key Clinical Questions Answered:

• Can TSA confiscate my pen needles?
  No. TSA security officers are legally permitted to inspect medical needles, but they cannot confiscate unused or used needles when accompanied by injectable medication.
• What should I do if my pen freezes in a hotel mini-fridge?
  If your GLP-1 pen freezes, you must discard it. Freezing denatures the peptide structure, causing the liquid to turn cloudy and lose clinical efficacy.
• Can my injection pens go through the airport X-ray machine?
  Yes. Airport luggage and checkpoint X-ray scanners use low-energy radiation that does not damage protein or peptide bonds.
• How do I dispose of used pen needles while staying in hotels?
  Never throw loose needles into hotel trash cans. Use a portable pocket sharps container or a heavy-plastic screw-top bottle labeled 'Sharps'.
• Do I need a doctor's letter for international flights?
  For domestic and most international travel, the original pharmacy carton displaying your name and prescription details is universally accepted.

Read the full clinical protocol on GLPme →

Why delayed gastric emptying causes severe constipation and foul sulfur burps, why common fiber advice makes it worse, and the clinical 3-step relief ladder.

30-Second Clinical Verdict: Gastrointestinal stagnation is the single most common cause of discontinuation on Ozempic, Wegovy, Mounjaro, and Zepbound, but it is completely preventable with the correct pharmacological ladder. GLP-1 receptor agonists delay gastric emptying and slow colonic transit time by 30% to 50%. When constipation strikes: (1) Stop taking bulk fiber (Metamucil / psyllium husk): in a slowed digestive tract, dry bulk fiber swells into a dense, unmovable mass that worsens impaction unless paired with gallons of water; (2) Use osmotic laxatives first: Polyethylene Glycol 3350 (MiraLAX) draws systemic water into the stool without causing painful intestinal cramping; (3) Neutralize sulfur burps with chemistry: rotten-egg sulfur burps are caused by food fermenting in an emptied-too-slow stomach, releasing hydrogen sulfide gas. Bismuth subsalicylate (Pepto-Bismol) directly binds hydrogen sulfide molecules in minutes, halting the odor immediately.

Key Clinical Questions Answered:

• How many days without a bowel movement is considered dangerous?
  Going 3 consecutive days without a bowel movement warrants active intervention with MiraLAX and magnesium. If day 4 passes with no movement, no gas, and severe pain, seek emergency care.
• Can I take MiraLAX every day while on a GLP-1?
  Yes. Polyethylene Glycol 3350 is an osmotic laxative that is not absorbed into the bloodstream and does not cause dependency or lazy bowel syndrome.
• Why does Pepto-Bismol turn my stool or tongue black?
  This is harmless and normal. Bismuth combines with trace sulfur compounds in your gut to form bismuth sulfide, which is jet black.
• Why did my sulfur burps appear suddenly after months on the same dose?
  Sulfur burps spike when high-fat or sulfur-rich foods (steak, eggs) sit in the stomach during the peak 24–48 hours post-shot, especially if dehydrated.
• Does walking really help with GLP-1 constipation?
  Yes. Physical movement stimulates the parasympathetic nervous system and mechanically triggers peristalsis to reduce postprandial gastric retention.

Read the full clinical protocol on GLPme →

Why patients transition from semaglutide to tirzepatide, how to dose-match without under- or over-shooting, the mandatory 7-day half-life gap, and what side effects to anticipate.

30-Second Clinical Verdict: Switching from semaglutide (Ozempic, Wegovy) to tirzepatide (Mounjaro, Zepbound) is safe and common, but it must obey two biological rules: (1) The 7-Day Washout Gap: wait exactly seven days after your final semaglutide injection before administering your first tirzepatide dose — taking them closer together creates drug stacking and severe gastrointestinal distress; (2) Cross-Titrate Proportionately: never jump straight to 15 mg Tirzepatide even if you were on the maximum 2.0 mg or 2.4 mg semaglutide dose. Tirzepatide introduces glucose-dependent insulinotropic polypeptide (GIP) receptor activation that your body has zero tolerance for. Standard clinical switches transition 0.5 mg Ozempic to 2.5 mg or 5 mg Mounjaro; 1.0 mg Ozempic to 5 mg or 7.5 mg Mounjaro; and 2.0 mg Ozempic to 7.5 mg or 10 mg Mounjaro.

Key Clinical Questions Answered:

• Do I have to start at 2.5 mg Mounjaro if I was on 2.0 mg Ozempic?
  Not necessarily, but you cannot start at 15 mg. Most clinicians transition patients on maximum semaglutide to 7.5 mg or 10 mg Mounjaro. A 2.5 mg start is safest for sensitive stomachs, while 7.5 mg bridges existing metabolic tolerance without severe nausea.
• How many days should I wait between my last Ozempic shot and first Mounjaro shot?
  Exactly 7 days. Because semaglutide has a 7-day half-life, waiting 7 days allows serum drug levels to decline to the normal weekly trough before introducing the new peptide.
• Will I gain weight during the switch?
  Weight gain during a properly scheduled switch is rare. In clinical trials, patients switching to tirzepatide resumed weight loss or maintained stability immediately upon reaching equivalent therapeutic doses.
• Why does tirzepatide cause different side effects than semaglutide?
  Tirzepatide activates GIP receptors in addition to GLP-1. GIP alters intestinal electrolyte secretion and energy balance, which can cause temporary loose stools rather than the severe constipation often seen on Ozempic.
• Can I switch back to Ozempic if I don't like Mounjaro?
  Yes. If a patient experiences intolerable side effects on tirzepatide, clinicians can transition back to semaglutide using the same 7-day washout interval and conservative dose matching.

Read the full clinical protocol on GLPme →

Why hunger and obsessive food chatter spike 48 hours before your next injection, how half-life clearance drives it, and 5 tactical rules to maintain control without early dosing.

30-Second Clinical Verdict: Experiencing hunger and food thoughts 48 hours before your next injection is a direct biological consequence of drug clearance, not personal weakness or medication failure. Semaglutide has an elimination half-life of 7 days, and tirzepatide has a half-life of approximately 5 days. By day 5 and 6 post-injection, circulating serum drug concentration has dropped by 30% to 40% from peak levels, and gastric emptying speeds back up from 4 hours toward normal. When this happens: (1) Do not inject early: taking your shot on Day 5 stacks peak concentrations and induces severe nausea when the overlapping doses peak together; (2) Anchor with 35g solid protein: eggs, chicken, and Greek yogurt naturally stimulate endogenous peptide release and slow gastric transit; (3) Distinguish physical hunger from compulsive noise: true physical hunger is healthy, expected, and satisfied by real food, while food noise is dopamine-seeking craving chatter.

Key Clinical Questions Answered:

• Why am I suddenly starving 2 days before my Ozempic injection?
  Semaglutide serum levels peak 1 to 3 days after injection and decline by roughly 35% by Day 5. As medication clears, gastric motility speeds up and stomach empties faster, triggering normal hunger hormones.
• Can I take my Ozempic or Mounjaro shot 2 days early to avoid food noise?
  No. Taking weekly injections every 5 days causes pharmacologic dose stacking, raising steady-state blood levels far above approved safety margins and dramatically increasing severe vomiting and gallbladder risks.
• Does food noise returning mean the medication stopped working?
  Not at all. Cyclic fluctuation between peak and trough is universal on once-weekly medications. True tolerance occurs when food noise returns on Day 1 or 2 and weight remains unchanged for 4 weeks.
• What foods best suppress food noise on Days 5 and 6?
  Solid lean proteins (eggs, chicken breast, Greek yogurt, salmon) and high-volume fiber (broccoli, chia seeds). These stimulate native gut satiety peptides and physically occupy stomach volume.
• Is it normal to have some appetite on GLP-1 medications?
  Yes. Healthy appetite regulation is the goal of GLP-1 therapy, not total starvation. Eating adequate calories and protein preserves lean muscle tissue and prevents metabolic adaptation.

Read the full clinical protocol on GLPme →

Does injecting in the thigh really reduce nausea compared to the abdomen? What clinical trials prove, the 4-quadrant rotation system to prevent scar tissue, and how to stop needle stinging.

30-Second Clinical Verdict: Clinical pharmacokinetic studies demonstrate that injecting in the thigh produces a smoother, slower peak absorption (Cmax) than the abdomen, significantly reducing acute nausea and vomiting while maintaining identical therapeutic weight loss. In clinical comparisons: (1) Abdomen (Stomach): yields the fastest absorption and highest peak blood levels, which maximizes initial appetite suppression but triggers the highest rate of nausea, reflux, and vomiting; (2) Thigh (Front/Outer): absorbs slightly slower, flattening the sharp drug spike and providing immediate relief for patients with severe gastrointestinal sensitivity; (3) Upper Arm (Back): intermediate absorption rate, but requires assistance or awkward positioning with auto-injector pens; (4) Eliminate Stinging: let your cold pen sit at room temperature for 20 minutes before injecting and let the alcohol swab dry 100% — wet alcohol causes 90% of injection pain.

Key Clinical Questions Answered:

• Does injecting Ozempic in the thigh cause less nausea than the stomach?
  Yes. Pharmacokinetic studies confirm that subcutaneous thigh injections result in a lower, more gradual peak drug concentration (Cmax), significantly reducing acute nausea and vomiting.
• Will injecting in the thigh reduce my weight loss results?
  No. Total drug exposure over 7 days (area under the curve) is clinically identical across abdomen, thigh, and upper arm sites. Weight loss outcomes in clinical trials are equivalent.
• Why does my Ozempic or Mounjaro injection burn when I inject?
  Injecting cold liquid straight from the refrigerator and pushing needles through wet alcohol are the two primary causes of burning. Let the pen warm for 20 minutes and let alcohol dry completely.
• What happens if a drop of medicine leaks out after injecting?
  A single drop on the needle tip or skin is normal. If significant liquid leaks out, you withdrew the needle too quickly — always hold the needle in place for 6 full seconds after the injection finishes.
• How far from my belly button should I inject?
  Stay at least 2 inches away from your navel. The tissue immediately surrounding the navel has dense fibrous umbilical ligaments that impair proper subcutaneous absorption.

Read the full clinical protocol on GLPme →

A 100% private, on-device GLP-1 companion app for iPhone. Log your weekly injections, model half-life decay curves, rotate shot sites, and track weight with zero subscription paywalls.

Companion FAQ:

• Is GLPme really free to track GLP-1 injections?
  Yes. GLPme's core logging engine — recording your shot dates, doses, injection sites, weight trend, and active medication half-life curves — is permanently free on iOS with zero subscription paywalls.
• Does GLPme work for both Ozempic and Mounjaro?
  Yes. GLPme supports all brand-name GLP-1 and dual GIP/GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) as well as compounded semaglutide and tirzepatide from licensed compounding pharmacies.
• How does GLPme protect my health data privacy?
  All data is stored exclusively on your iPhone using local on-device encryption. GLPme requires no email account creation, operates completely offline, and never sells or brokers your medical records to advertisers.
• Can I calculate compounded syringe units in the app?
  Yes. GLPme features a built-in compounded vial calculator that instantly converts your prescribed dose in milligrams into the exact syringe units mark on standard U-100 insulin syringes.

Explore the companion guide on GLPme →

Track your weekly Ozempic injections, navigate the 4-week titration ladder, visualize active semaglutide half-life levels, and prevent tissue scarring with guided site rotation on iOS.

Companion FAQ:

• How does GLPme help with the Ozempic titration schedule?
  GLPme tracks your current dose (0.25 mg, 0.5 mg, 1.0 mg, or 2.0 mg), monitors your 4-week escalation timeline, and reminds you when your body has adapted and is ready for clinical dose review.
• Why does food noise return on Day 5 or Day 6 of Ozempic?
  Semaglutide has an elimination half-life of 7 days. By Day 5, active circulating drug levels drop to roughly 60% of peak concentration. GLPme graphs this active decay curve so you can anticipate hunger return.
• Can I track compounded semaglutide on GLPme?
  Yes. GLPme supports both pre-filled commercial Ozempic pens and multi-dose compounded vials, automatically converting milligrams into exact syringe units on U-100 syringes.

Explore the companion guide on GLPme →

Precision tracking for dual GIP and GLP-1 receptor agonism. Model tirzepatide's 5-day half-life curve, track the 6-step escalation ladder up to 15 mg, and log blood glucose correlations on iOS.

Companion FAQ:

• Why does Mounjaro clear faster than Ozempic?
  Tirzepatide has an elimination half-life of 5 days (120 hours) compared to semaglutide's 7 days. GLPme models this faster clearance curve so you know when active receptor occupancy drops.
• Can I log extended dose-spacing (e.g. every 10 days) on Mounjaro?
  Yes. GLPme is built for custom injection intervals, modeling your rolling blood levels whether you inject every 7, 10, or 14 days for long-term glycemic maintenance.
• Does GLPme work with compounded tirzepatide vials?
  Yes. GLPme instantly calculates the exact syringe units for 10 mg/mL, 20 mg/mL, and custom compounded concentrations on standard U-100 syringes.

Explore the companion guide on GLPme →

Engineered for the SURMOUNT protocol. Track your weekly tirzepatide injections, calculate personalized daily protein floors to protect muscle mass, and monitor the 3 approved maintenance doses on iOS.

Companion FAQ:

• How does GLPme help prevent muscle loss on Zepbound?
  GLPme computes a personalized daily protein target (typically 1.2 to 1.6 g/kg) and helps you split it into 30g gentle meal portions to safeguard skeletal muscle while shedding adipose fat.
• What are the 3 approved maintenance doses of Zepbound?
  The FDA approved 5.0 mg, 10.0 mg, and 15.0 mg once weekly as long-term maintenance doses. GLPme lets you hold at your personalized maintenance tier indefinitely.
• Can I track side effects like sulfur burps in GLPme?
  Yes. GLPme features a dedicated symptom log that correlates gastrointestinal symptoms with injection timing and identifies high-fat dietary triggers.

Explore the companion guide on GLPme →

Navigate the 16-week titration ladder to 2.4 mg semaglutide. Track weekly auto-injector pen shots, model active 7-day half-life curves, and benchmark your progress against the STEP 1 trial on iOS.

Companion FAQ:

• How does GLPme assist with the Wegovy escalation schedule?
  GLPme tracks your current month (0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, or 2.4 mg), warns you before your 4-pen box finishes, and reminds you when your clinical step-up appointment is due.
• What if I miss my weekly Wegovy injection?
  If your next scheduled dose is more than 2 days away, take the missed dose immediately. If less than 2 days remain, skip it. If you miss for more than 2 weeks, consult your prescriber about restarting titration.

Explore the companion guide on GLPme →

The first companion app built specifically for compounded semaglutide vials. Convert prescribed milligrams directly to syringe units (U-100), track vial beyond-use dates (BUD), and model half-life curves on iOS.

Companion FAQ:

• How does GLPme prevent compounded semaglutide dosing mistakes?
  GLPme translates prescribed milligrams (e.g. 0.25 mg or 0.5 mg) into exact syringe units based on your vial's concentration, displaying a rendered syringe graphic so you draw the correct volume.
• How long is a compounded semaglutide vial safe after puncturing?
  Most compounding pharmacies state a Beyond-Use Date (BUD) of 28 to 60 days once punctured. GLPme tracks your puncture date and warns you before microbial contamination risk rises.

Explore the companion guide on GLPme →

Engineered for compounded tirzepatide vials. Convert mg to syringe units across 10 mg/mL, 20 mg/mL, and custom concentrations, model 5-day dual-agonist half-life curves, and forecast reorder dates on iOS.

Companion FAQ:

• How do I calculate units for 20 mg/mL compounded tirzepatide?
  Divide your prescribed mg dose by 20 and multiply by 100. For example, a 5.0 mg dose is 25 units on a U-100 syringe. GLPme performs this calculation automatically to eliminate math mistakes.
• Why does GLPme track vial reorder dates?
  Compounded pharmacies frequently require 7 to 14 days to process and ship tirzepatide orders. GLPme computes remaining doses and notifies you 10 days before your vial runs out.

Explore the companion guide on GLPme →

Correlate nausea, constipation, acid reflux, and sulfur burps with your weekly injection timing. Discover dietary fat triggers, model peak-concentration windows, and access evidence-based recovery protocols.

Companion FAQ:

• Why do GLP-1 side effects peak 24 to 48 hours after injection?
  Subcutaneous semaglutide and tirzepatide reach peak plasma concentration (Tmax) between 24 and 48 hours post-shot. Gastric motility is most severely slowed during this peak, triggering nausea and reflux.
• How does injecting in the thigh reduce nausea?
  Pharmacokinetic trials show that thigh injections produce a slightly lower and more gradual peak blood concentration (Cmax) than abdominal injections, dramatically reducing acute nausea.
• What should I take for GLP-1 constipation?
  Clinical guidelines recommend osmotic laxatives like polyethylene glycol (MiraLAX) or magnesium citrate paired with abundant hydration, rather than bulk-forming psyllium husk which can worsen gut stalls.

Explore the companion guide on GLPme →

Compañero clínico 100% privado en tu dispositivo. Modela niveles de semaglutida en sangre, registra la rotación de zonas de inyección y anticipa el hambre del día 5 sin suscripciones mensuales.

Preguntas Frecuentes:

• ¿Qué pasa si olvido una dosis de Ozempic?
  Si han transcurrido menos de 5 días, inyecta la dosis olvidada de inmediato. Si han pasado más de 5 días, salta esa dosis y espera a la siguiente fecha programada.
• ¿Se puede usar GLPme con semaglutida compuesta o magistral?
  Sí. GLPme incluye una calculadora directa de miligramos a unidades de jeringa U-100 para frascos multidosis.
• ¿Requiere registro o correo electrónico?
  No. GLPme funciona de manera 100% privada en tu iPhone sin cuentas en la nube ni suscripciones.

Leer la guía completa en español en GLPme →

Convierte miligramos (mg) de semaglutida a unidades exactas en jeringas de insulina U-100 para cualquier concentración de frasco (2.5 mg/mL, 5 mg/mL). Incluye tablas y fórmulas de seguridad.

Preguntas Frecuentes:

• ¿Cuántas unidades son 0.25 mg de semaglutida?
  En un frasco de 2.5 mg/mL son 10 unidades. En un frasco de 5 mg/mL son 5 unidades en jeringa U-100.
• ¿Qué es una jeringa U-100?
  Es una jeringa de insulina calibrada de modo que 100 unidades corresponden a 1.0 mililitro (mL).
• ¿Cuál es la fórmula para calcular unidades?
  Unidades = (Dosis prescrita en mg / Concentración en mg/mL) * 100.

Leer la guía completa en español en GLPme →

Compañero clínico privado para la doble acción GIP y GLP-1. Modela la vida media de 5 días de la tirzepatida, registra la escala de titulación hasta 15 mg y rota sitios de inyección sin suscripciones.

Preguntas Frecuentes:

• ¿Qué hago si olvido una dosis de Mounjaro?
  Si han transcurrido 4 días o menos desde la fecha programada, inyéctala en cuanto lo recuerdes. Si han pasado más de 4 días, salta esa dosis y espera a tu día habitual.
• ¿Se puede registrar tirzepatida formulada o magistral?
  Sí. GLPme incluye una calculadora directa de miligramos a unidades de jeringa U-100 para frascos multidosis.
• ¿Requiere crear cuenta o pagar suscripción?
  No. GLPme funciona de manera 100% privada y gratuita en tu iPhone sin cuentas ni pagos obligatorios.

Leer la guía completa en español en GLPme →

Convierte miligramos (mg) de tirzepatida a unidades exactas en jeringas de insulina U-100 para cualquier concentración de frasco (10 mg/mL, 20 mg/mL, 10 mg en 2 mL). Incluye tabla médica de dosis.

Preguntas Frecuentes:

• ¿Cuántas unidades son 2.5 mg de tirzepatida?
  En un frasco de 10 mg/mL son 25 unidades. En un frasco de 20 mg/mL son 12.5 unidades en jeringa U-100.
• ¿Cuántas unidades son 5 mg de tirzepatida?
  En un frasco de 10 mg/mL son 50 unidades. En un frasco de 20 mg/mL son 25 unidades.
• ¿Cuál es la fórmula para calcular unidades?
  Unidades = (Dosis prescrita en mg / Concentración en mg/mL) * 100.

Leer la guía completa en español en GLPme →

Read full teardown on GLPme →

Read full teardown on GLPme →

Read full teardown on GLPme →

Read full teardown on GLPme →